Jump Financial LLC Trims Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Jump Financial LLC lessened its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 96.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,189 shares of the medical device company's stock after selling 81,867 shares during the period. Jump Financial LLC's holdings in Cooper Companies were worth $293,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Byrne Asset Management LLC purchased a new position in Cooper Companies during the fourth quarter valued at approximately $33,000. OFI Invest Asset Management purchased a new position in shares of Cooper Companies in the fourth quarter valued at about $34,000. New Age Alpha Advisors LLC purchased a new stake in shares of Cooper Companies during the fourth quarter worth about $38,000. Covestor Ltd raised its stake in Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares during the period. Finally, West Financial Advisors LLC purchased a new position in Cooper Companies in the 4th quarter worth approximately $49,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Performance

Cooper Companies stock traded up $0.38 during mid-day trading on Tuesday, reaching $82.23. 1,156,744 shares of the company traded hands, compared to its average volume of 1,423,452. The Cooper Companies, Inc. has a fifty-two week low of $69.81 and a fifty-two week high of $112.38. The firm's fifty day moving average is $81.91 and its two-hundred day moving average is $92.34. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market capitalization of $16.44 billion, a price-to-earnings ratio of 42.17, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the topic of several research analyst reports. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Stifel Nicolaus decreased their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. BNP Paribas raised Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Robert W. Baird lowered their target price on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.